Health Claims

Computer models show electrons move from zinc hydroxystannate to titanium dioxide at their interface following a specific pathway.

Mechanistic

Scientists observed that benzene breaks down into smaller molecules like phenolate, acetate, maleate, and methylene during the cleaning process using a special light-based technique.

Mechanistic

This new catalyst cleans benzene from air using UV light, processing 1.71 liters of air per minute, removing benzene at 21.9 micromoles per gram per hour, and using light efficiently with a quantum yield of 0.000608 molecules per photon per gram.

Quantitative

Tesamorelin only targets dangerous belly fat in HIV patients, leaving other fat stores like arms and legs unchanged.

Descriptive

Tesamorelin boosts a key growth hormone-related protein in HIV patients without affecting their blood sugar levels.

Causal

Doctors see noticeable improvements in the belly shape of HIV patients taking tesamorelin, while those on a dummy pill show no change.

Causal

HIV patients with belly fat buildup feel better about their appearance after taking tesamorelin, while those on a dummy pill don't notice a difference.

Causal

If HIV patients stop taking tesamorelin and switch to a dummy pill, their dangerous belly fat quickly returns to previous levels.

Causal

Continuing tesamorelin for a full year helps HIV patients with belly fat lose nearly 18% of their dangerous internal belly fat, with no loss of benefit over time.

Causal

A drug called tesamorelin helps HIV patients with belly fat buildup lose about 11% of their dangerous internal belly fat in six months, while those on a dummy pill lose almost none.

Causal

Cells with MOTS-c used less oxygen, but adding folic acid brought oxygen use back to normal.

Mechanistic

MOTS-c injections made mice burn more glucose instead of fat, as shown by higher CO2 output relative to oxygen use.

Quantitative

When mice fasted, MOTS-c levels dropped in muscles and blood but stayed the same in brain and heart.

Descriptive

Muscle cells engineered to produce MOTS-c used up glucose from their environment faster than normal cells.

Quantitative

MOTS-c injections reduced fat buildup in the livers of mice eating a high-fat diet, as seen in tissue samples.

Descriptive

Old mice that got MOTS-c for a week had muscle glucose uptake as good as young mice, reversing age-related insulin resistance.

Quantitative

When cells made extra MOTS-c, they had 20 times more AICAR, which turned on AMPK, a key energy regulator.

Mechanistic

For people with HIV taking tesamorelin, changes in their growth hormone levels didn't match changes in their trunk muscle thickness or size.

Correlational

MOTS-c injections made muscle cells more responsive to insulin by activating AMPK and increasing GLUT4, which helps move glucose into cells.

Mechanistic

For people with HIV taking tesamorelin, losing belly fat was linked to thicker, denser muscles in the abdominal and rectus areas.

Correlational

After a week of MOTS-c injections, mice could process insulin better, needing 30% more glucose to keep blood sugar stable during a test.

Quantitative

When mice ate a high-fat diet, daily MOTS-c injections helped them stay lighter than untreated mice, even though they ate the same amount of food.

Quantitative

People with HIV and belly fat who responded to tesamorelin by losing belly fat saw their rectus and psoas muscles grow 0.44 cm² and 0.46 cm² larger than those on placebo after 26 weeks of treatment.

Causal

People with HIV and belly fat who responded to tesamorelin by losing belly fat saw their trunk muscles grow larger in specific areas: rectus abdominis by 0.85 cm², psoas by 0.64 cm², and others by up to 1.08 cm² more than those on placebo after 26 weeks.

Causal